Dubbed the Artificial Intelligence Lab for Biosciences (AI4B.io), the facility will be the first in Europe to apply AI to full-scale biomanufacturing, from microbial strain development to process optimization and scheduling.
The AI4B.io Lab will be part of the Dutch National Innovation Center for AI, which works to keep the Netherlands at the forefront of knowledge and talent development in AI. It will be led by Professor Marcel Reinders, Director TU Delft Bioengineering Institute. DSM will invest €2.5 million (US$3.0 million) into the laboratory over the first five years.
‘’Biotechnology can contribute significantly to solving major societal challenges, such as climate change, healthy nutrition for the world’s rapidly growing population, and raw material scarcity. AI plays a crucial role in the development of biotechnology applications, but—scientifically speaking—there are still many unanswered questions at the cellular, lab, and process level. By linking our fundamental research to concrete opportunities at DSM, we can maximize our impact,” Professor Marcel Reinders, Director TU Delft Bioengineering Institute says in a statement.